Ga. Comp. R. & Regs. R. 480-10A-.05 - Transmission and Labeling

(1) The transmission and labeling of controlled substance prescriptions processed utilizing central fill services must comply with all federal and state laws, rules, and regulations.

(2) The originating pharmacy must comply with the minimum required information for the patient record system and all requirements of a prescription drug order as outlined in the Georgia law and Board rules prior to sending a prescription to the central fill pharmacy.

(3) All prescriptions may be transmitted electronically from an originating pharmacy to a central fill pharmacy including via facsimile.

(4) All transmission records must include the following:

(a) "CENTRAL FILL" written on the face of a prescription if it is a hard copy prescription,

(b) The name, address, telephone number, Georgia license number, and DEA registration number (if the prescription is a controlled substance), of the central fill pharmacy to which the prescription has been transmitted,

(c) Number of refills already dispensed and number of refills remaining (if applicable),

(d) The name of the originating pharmacy pharmacist transmitting the prescription, and

(e) The date of transmittal.

(5) All receipt of transmission records must include all information included in subsection 4 and the name, address, telephone number, Georgia license number, and DEA registration number (if the prescription is a controlled substance), of the originating pharmacy transmitting the prescription.

(6) The label affixed to the container of a dangerous drug or other non-controlled substance filled by a central fill pharmacy must contain the following:

(a) Date of fill or refill,

(b) The originating pharmacy name, address, and telephone number,

(c) The central fill pharmacy's unique identifier,

(d) The serial number of the prescription,

(e) The name of the patient,

(f) The name of the prescribing practitioner,

(g) Name of supervising physician if applicable,

(h) Expiration date of the dispensed drug, and

(i) The directions for use and cautionary statements, if any, contained in such prescription or required by law.

Notes

Ga. Comp. R. & Regs. R. 480-10A-.05

O.C.G.A. § 26-4-60.

Original Rule entitled "Transmission and Labeling" adopted. F. Nov. 15, 2019; eff. Dec. 5, 2019.